Eduard Vieta

Active 1996–2025

628
Papers
77,204
Citations
149
h-index
590
i10-index

Citations

Citations per year for Eduard Vieta1972: 3 citations1977: 1 citations1986: 3 citations1998: 1 citations1999: 6 citations2000: 10 citations2001: 22 citations2002: 30 citations2003: 30 citations2004: 97 citations2005: 169 citations2006: 168 citations2007: 240 citations2008: 324 citations2009: 454 citations2010: 400 citations2011: 515 citations2012: 461 citations2013: 533 citations2014: 516 citations2015: 562 citations2016: 599 citations2017: 457 citations2018: 611 citations2019: 1,983 citations2020: 2,521 citations2021: 2,463 citations2022: 2,054 citations2023: 1,616 citations2024: 2,837 citations2025: 1,299 citations2026: 50 citations1973–1976: no citations, so these years are not shown1978–1985: no citations, so these years are not shown1987–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,889 citing papers, 17.9% of this breakdownUnited Kingdom: 1,792 citing papers, 8.2% of this breakdownCanada: 1,422 citing papers, 6.5% of this breakdownChina: 1,410 citing papers, 6.5% of this breakdownItaly: 1,321 citing papers, 6.1% of this breakdownSpain: 1,282 citing papers, 5.9% of this breakdownGermany: 1,070 citing papers, 4.9% of this breakdownAustralia: 1,035 citing papers, 4.8% of this breakdownNetherlands: 651 citing papers, 3% of this breakdownBrazil: 604 citing papers, 2.8% of this breakdownFrance: 554 citing papers, 2.5% of this breakdownDenmark: 466 citing papers, 2.1% of this breakdown
0%17.9%Other 28.8%

Fields

  • Medicine56.4%
  • Neuroscience16.9%
  • Psychology14.9%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Health Professions1.3%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Other3.9%

Topics

  • Bipolar Disorder and Treatment12.3%
  • Schizophrenia research and treatment8%
  • Tryptophan and brain disorders6.3%
  • Treatment of Major Depression5.6%
  • Functional Brain Connectivity Studies3.4%
  • Mental Health Research Topics2.4%
  • Other62%

Coauthors

All papers

Open in search
  1. Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 cited by 690

  2. Bipolar disorders

    Authors: , , , , , , , , , , , , , - The Lancet 2020 cited by 981

  3. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Bipolar Disorders 2018 cited by 1,770

  4. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2021 cited by 689

  5. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

    Authors: , , , , , , , , , , , , , , , - American Journal of Psychiatry 2019 cited by 872

  6. Bipolar disorder

    Authors: , , , - The Lancet 2015 cited by 1,631

  7. Bipolar disorders

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2018 cited by 810

  8. Bipolar Disorder

    Authors: , , - New England Journal of Medicine 2020 cited by 534

  9. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 cited by 245

  10. The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

    Authors: , , , , - Psychotherapy and Psychosomatics 2016 cited by 657

  11. How mental health care should change as a consequence of the COVID-19 pandemic

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 1,889

  12. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Bonnin, Maria Francesca Ponteduro, Maria Keil, Maria M. Rive, Nailin Yao, Nefize Yalın, Pablo Najt, Pedro G. P. Rosa, Ronny Redlich, Sarah Trost, Saskia P. Hagenaars, Scott C. Fears, Sílvia Alonso-Lana, Theo G.M. van Erp, Thomas E. Nickson, Tiffany Chaim-Avancini, Timothy B. Meier, Torbjørn Elvsåshagen, Unn K. Haukvik, W H Lee, Aart H. Schene, Adrian J. Lloyd, Allan H. Young, Allison C. Nugent, Anders M. Dale, Andrea Pfennig, Andrew M. McIntosh, Beny Lafer, Bernhard T. Baune, Carl Johan Ekman, Carlos A. Zarate, Carrie E. Bearden, Chantal Henry, Christian Simhandl, Colm McDonald, Corin Bourne, Dan J. Stein, Daniel H. Wolf, Dara M. Cannon, David C. Glahn, Dick J. Veltman, Edith Pomarol‐Clotet, Eduard Vieta, Erick J. Canales‐Rodríguez, Fabiano G. Nery, Fábio Duran, Geraldo F. Busatto, Gloria Roberts, Godfrey D. Pearlson, Guy M. Goodwin, Harald Kugel, Heather C. Whalley, Henricus G. Ruhé, Jair C. Soares, Janice M. Fullerton, Janusz Rybakowski, Jonathan Savitz, Kalil T Chaim, Mar Fatjó‐Vilas, Márcio Gerhardt Soeiro‐de‐Souza, Marco P. Boks, Marcus V. Zanetti, Maria Concepción García Otaduy, Maria Schaufelberger, Martin Alda, Martin Ingvar, Mary L. Phillips, Matthew J. Kempton, Michael Bauer, Mikael Landén and 24 more - Molecular Psychiatry 2017 cited by 815

  13. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aleix Solanes, Anton Albajes‐Eizagirre, Erick J. Canales‐Rodríguez, Salvador Sarró, Annabella Di Giorgio, Alessandro Bertolino, Michael Stäblein, Viola Oertel, Christian Knöchel, Stefan Borgwardt, Stefan S. du Plessis, Je‐Yeon Yun, Jun Soo Kwon, Udo Dannlowski, Tim Hahn, Dominik Grotegerd, Clara Alloza, Celso Arango, Joost Janssen, Covadonga M. Díaz‐Caneja, Wenhao Jiang, Vince D. Calhoun, Stefan Ehrlich, Kun Yang, Nicola G. Cascella, Yoichiro Takayanagi, Akira Sawa, A. S. Tomyshev, И. С. Лебедева, В. Г. Каледа, Matthias Kirschner, Cyril Höschl, David Tomeček, Antonín Škoch, Thérèse van Amelsvoort, Geor Bakker, Anthony James, Adrian Preda, Andrea Weideman, Dan J. Stein, Fleur M. Howells, Anne Uhlmann, Henk Temmingh, Carlos López‐Jaramillo, Ana M. Díaz‐Zuluaga, Lydia Fortea, Eloy Martínez‐Heras, Elisabeth Solana, Sara Llufriú, Neda Jahanshad, Paul M. Thompson, Jessica A. Turner, Theo G.M. van Erp, David C. Glahn, Godfrey D. Pearlson, Elliot Hong, Axel Krug, Vaughan J. Carr, Paul A. Tooney, Gavin Cooper, Paul E. Rasser, Patricia T. Michie, Stanley V. Catts, Raquel E. Gur, Ruben C. Gur, Fude Yang, Fengmei Fan, Jingxu Chen, Hua Guo, Shuping Tan and 11 more - NeuroImage 2020 cited by 274

  14. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder

    Authors: , , , , , , , , , , , - Clinical Practice and Epidemiology in Mental Health 2007 cited by 898

  15. Voxel-based meta-analysis via permutation of subject images (PSI): Theory and implementation for SDM

    Authors: , , , - NeuroImage 2018 cited by 298

  16. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Psychopharmacology 2016 cited by 1,296

  17. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

    Authors: , , , , , , , , , , , , , , , , , , - World Psychiatry 2022 cited by 157

  18. Insulin resistance in depression: A large meta-analysis of metabolic parameters and variation

    Authors: , , , , , - Neuroscience & Biobehavioral Reviews 2022 cited by 146

  19. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

    Authors: , , , , , , , , , , , - Therapeutics and Clinical Risk Management 2017 cited by 424

  20. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability

    Authors: , , , , , , , , , , , , , - Brain Behavior and Immunity 2021 cited by 185

  21. Association between completed suicide and bipolar disorder: A systematic review of the literature

    Authors: , , , , , , , , - Journal of Affective Disorders 2018 cited by 271

  22. Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen M. Lawrie, Julia Linke, Andrew M. McIntosh, Elisa Melloni, Philip B. Mitchell, Mircea Polosan, Edith Pomarol‐Clotet, Jonathan Repple, Gloria Roberts, Annerine Roos, Pedro G. P. Rosa, Raymond Salvador, Salvador Sarró, Peter R. Schofield, Maurício H. Serpa, Kang Sim, Dan J. Stein, Jess E. Sussmann, Henk Temmingh, Paul M. Thompson, Norma Verdolini, Eduard Vieta, Michèle Wessa, Heather C. Whalley, Marcus V. Zanetti, Marion Leboyer, Jean‐François Mangin, Chantal Henry, Édouard Duchesnay, Josselin Houenou - Neuropsychopharmacology 2019 cited by 235

  23. Structural brain correlates in major depression, anxiety disorders and post-traumatic stress disorder: A voxel-based morphometry meta-analysis

    Authors: , , , , , , , , , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2021 cited by 114

  24. The elephant in the room: Medication as confounder

    Authors: , - European Neuropsychopharmacology 2023 cited by 84